Related to renal replacement therapy (RRT) | Related to central venous catheter (CVC) |
---|---|
RRT-associated hypotension: | Hemorrhage at the site of CVC insertion: |
Drop in blood pressure requiring one of: initiation of a vasopressor during RRT session, or need to escalate dose of a vasopressor during the RRT session, or premature discontinuation of RRT session, or any other intervention to stabilize blood pressure. | Bleeding requiring transfusion of ≥1 unit(s) of packed red blood cells and/or surgical intervention/repair within 12 hours following insertion |
Severe hypophosphatemia: | CVC-associated bloodstream infection: |
Serum phosphorus <0.5 mmol/L | Bacteremia in 2 blood culture sets with no proven alternative source for bacteremia or culture-positive recovery of the same organism from the dialysis catheter upon removal |
Severe hypokalemia: | Ultrasonographically-confirmed thrombus attributed to CVC |
Serum potassium <3.0 mmol/L | |
Severe hypocalcemia: | Pneumothorax (for catheters placed in the internal jugular or subclavian positions) |
Albumin-adjusted serum calcium <2.00 mmol/L or ionized calcium <1.00 mmol/L | |
Allergic reaction | Hemothorax (for catheters placed in the internal jugular or subclavian positions) |
Arrhythmia during dialysis: | Air embolism |
New atrial (excluding sinus tachycardia or sinus arrhythmia) or ventricular arrhythmia that develops during RRT and was not present prior to initiation of RRT | |
Seizure | Inadvertent arterial puncture at time of CVC insertion |
Hemorrhage in patient receiving RRT with heparin-based anticoagulation | Other CVC-related adverse events |